The Korean Collaborative Study on 11,000 Prenatal Genetic Amniocentesis

Yonsei Medical Journal

Volumn 40, Issue 5, 1999, Pages 460-466

  Yang, Young Ho ^a   Ju, Kap Soon ^b   Kim, Seung Bo ^c   Cho, Yul Hee ^d   Lee, Je Ho ^e   Lee, Sook Hwan ^f   Choi, Ook Hwan ^g   Chun, Jeong Hee ^h   Kim, Jong In ⁱ   Kim, Hyon Ju ^j   Sohn, Yong Seok ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

^d Hanyang University College of Medicine   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f CHA General Hospital   (South Korea)

^g Pusan National University School of Medicine   (South Korea)

^h Il Sin Christian Hospital   (South Korea)

ⁱ Keimyung University   (South Korea)

^j Ajou University School of Medicine   (South Korea)

more..

Author keywords

Amniocentesis; Chromosomal abnormality; Indication; Prenatal diagnosis

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AMNIOCENTESIS; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME DISORDER; ECHOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; KOREA; MATERNAL AGE; PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; AMNIOCENTESIS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; GESTATIONAL AGE; HUMANS; KOREA; MATERNAL AGE; PREGNANCY; ULTRASONOGRAPHY, PRENATAL;

EID: 0033203060     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1999.40.5.460     Document Type: Article

References (37)

1. Schatz F. Eine besondere art von ein seitiger polyhydamnic mit anderseitiger oligohydramnie bei Zwillingen. Arch Gynaekol 1982;19:329-37.
2. Fuchs F, Rüs P. Antenatal sex determination. Nature 1956;177:330-4.
3. Steele MW, Breg WR. Chromosome analysis of human fluid cells. Lancet 1966;1:383-5.
4. Jacobsen CB, Barter RH. Intrauterine diagnosis and mangement of genetic defects. Am J Obstet Gynecol 1967;99:796-807.
5. Golbus MS, Loughman WD, Epstein CJ, Halkasch G, Stephens JD, Hall BD. Prenatal genetic diagnosis in 3000 amniocentesis. N Engl J Med 1979;300:157-63.
6. Harrison R, Campbell S. Risks of feto-maternal hemorrhage resulting from amniocentesis with and without ultrasound placental localization. Obstet Gynecol 1975;86:89-91.
7. Dacus JV, Wilroy RS, Summitt RL, Garbaciak JA, Abdella TN, Spiannato JA, et al. Genetic amniocentesis: A twelve year's experience. Am J Med Genet 1985;20:443-52
8. Bell JA, Pearn JH, Wilson BH, Ansford AJ. Prenatal cytogenetic diagnosis-a current audit 1987 A review of 2000 cases of prenatal cytogenetic diagnosis after amniocentesis and comparisons with early experience. Med J Aust 1987;146:12-5.
9. Ju KS, Kim SB. Chromosome analysis of the mid-preg- nancy amniocentesis. Korean J Obstet Gynecol 1993;36:3576-88.
10. Little BB, Ramin SM, Cambridge BS, Schneider NR, Cohen DS, Snell LM, et al. Risk of chromosomal abnormalities with emphasis in liveborn in offspring of very young mothers. Am J Hum Genet 1995;57:1178-83.
11. Adams MM, Erickson JD, Layde PM, Oacley P. Down's syndrome: Recent trends in the United States. JAMA 1981;246:758-60.
12. Olsen CL, Cross PK. Trends in the use of prenatal diagnosis in New York state and the impact of biochemical screening on the detection of Down syndrome: 1984-1993. Prenat Diagn 1997;17:1113-24.
13. Wenstrom KD, Williamson RA, Grant SS, Hudson JD, Getchell JP. Evaluation of multiple-marker screening for Down syndrome in a statewide population. Am J Obstet Gynecol 1993;169:793-7.
14. Crandall BF, Robinson RD, Lebherx TB, King W, Schroth PC. Maternal serum alpha-fetoprotein screening for the detection of neural tube defects. West J Med 1983;138:524-30.
15. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alphafetoprotein and fetal chromosome abnormalities. Am J Obstet Gynecol 1984;148:886-94.
16. Dimaio MS, Baumgarten A, Greenstein R, Saal H, Mahoney M. Screening for fetal Down syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. N Engl J Med 1987;317:342-6.
17. Palomaki GE, Haddow JW, Maternal serum alphafetoprotein, age, and Down syndrome risk. Am J Obstet Gynecol 1987;156:460-3.
18. Wald NJ, Cuckle HS. sFP and age screening for Down syndrome. Proceedings of the American Society of Human Genetics Conference. October 1987. Am J Hum Genet 1988;31:197-209.
19. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down syndrome. Br J Obstet Gynecol 1987;95:330-3.
20. Bogart HM, Pandian MR, Jones CW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7:623-30.
21. Yang YH, Kwon HK, Kim SK, Park YW, Cho JS, Kim IK, et al. Prenatal genetic diagnosis in 2,000 amniocentesis. Korean J Obstet Gynecol 1999;42:65-71.
22. Vintzileos AM, Campbell WA, Nichimson DJ, Weinbaum PJ. Antenatal evaluation and management of ultrasonographically detected fetal anomalies. Obstet Gynecol 1987;69:640-60.
23. Nicolaides KH, Rodeck CH, Gosden CN. Rapid karyo- typing in nonlethal malformations. Lancet 1986;i:283-7.
24. Porto M, Murata Y, Warneke LA, Keegam KA. Fetal choroid plexus cysts: An Independent risk factor for chromosomal Anomalies J Clin Ultrasound 1993;21:103-8.
25. Deroo TR, Harris RD, Sargent SK, Denhom TA, Crow HC. Fetal choroid plexus cysts:prevalance, clinical significance and sonographic appearance. Am J Roentgenol 1988;151:1179-81.
26. Nadel AS, Bromley BS, Frigolette FD, Estroff JA, Benacerrtaf BR. Isolated choroid plexus cysts in the second- trimester fetus:Is amniocentesis really indicated? Radiology 1992;185:545-8.
27. Yagel S, Anteby EY, Celnikier DH, Ariel I, Chaap T, Neriah ZB. The role of midtrimester targeted fetal organ screening combined with the "triple test" and maternal age in the diagnosis of trisomy 21; a retrospective study. Am J Obstet Gynecol 1998;178:40-4.
28. Hogge WA, Thiagrajah S, Ferguson II JE, Schnatterly PT, Herbert GM. The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk for neural tube defects. Am J Obstet Gynecol 1989;161:520-4.
29. NICHD National Registry for Amniocentesis Study Group. Midtrimester amniocentesis for prenatal diagnosis, safety and accuracy. JAMA 1976;236:178-90.
30. Simpson NE, Dallaire L, Meller JR. Prenatal diagnosis of genetic disease in Canada: Report of a collaborative study. Can Med Assoc J 1976;15:739-46.
31. Crandall BF, Lebherz TB. Prenatal genetic diagnosis in 350 amniocentesis. Am J Obstet Gynecol 1976;48:158-62.
32. Cruikshank DP, Varner MW, Cruikshank JE, Grant SS, Donnelly E. Midtrimester amniocentesis. Am J Obstet Gynecol 1983;146:204-11.
33. Glass N. Economic aspects of the prevention of Down's syndrome. In: Bailey NTJ, Thompson M, editors. System aspects of health planning. Amsterdam (North-Holland): North-Holland Press; 1975. p.107.
34. Hagard S, Carter FA. Preventing The Birth of infants with Down's syndrome: A cost-benefit analysis. Br Med J 1976;1:753-6.
35. Mikkelsen M, Nielsen G, Rasmussen E. Cost-effectiveness of antenatal screening for chromosome abnormalities. In: Scrimgeour JB, editor. Towards the prevention of fetal malformation. Edinburgh: Edinburgh University Press; 1978. p.74.
36. Andreano RL, McCollum DW. A benefit-cost analysis of amniocentesis. Soc Biol 1983;30:347-73.
37. Holmes LB. Genetic counselling for the older pregnancy woman: new data and questions. N Engl J Med 1978;298:1419-21.